CytomX Therapeutics, Inc. (CTMX) Operating income 2016–2025
CytomX Therapeutics, Inc. (CTMX) annual operating income history from SEC filings — each fiscal year as reported.
-$22.4MFY2025 · since FY2016: -$59.6M → -$22.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$22.4M | -189.5% |
| FY2024 | $25.0M | +485.5% |
| FY2023 | -$6.5M | +93.6% |
| FY2022 | -$101.3M | +12.7% |
| FY2021 | -$116.0M | -44.1% |
| FY2020 | -$80.5M | +43.1% |
| FY2019 | -$141.5M | -81.7% |
| FY2018 | -$77.9M | -68.3% |
| FY2017 | -$46.3M | +22.4% |
| FY2016 | -$59.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice